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MRSA -A  2 step eradication protocol in a Regional Paediatric Centre 
in Northern Ireland 
M. Macfar lane, A. Leaw,  A. Reid, J. McCaughan, R. Pair 
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Complementary Therapy: Use bypatients attending the CF Clinic 
K. Griffiths 
Aberdeen Royallnfirmary, Aberdee~ Scot~uI, UK 
In t  reduct ion 220 patients attend the Regional Paediatric Centre ha Belfast. Prior to 
1999 only one of these patient cultured Methici l l in Resistant Staphylc~occus 
Aureus (MRSA) ha his sputum. 
In our centre from January 1999 January 2CO4 all children were investigated 
tbrough routine sputum cultures for MRSA mad a further 19 patients were identified 
with positive cultures. We report on the management of these patients, which has 
successfully eradicated MRSA in 16 out of the 19 patients. 
Methods 1. Sputum obtained at 3 monthly routine clinic visit 
2. Positive sputum CF Community Nurse visited and carried out multi  site swabs 
(nostrils x 2 ,  perineum, open wounds and sputum) 
3. Step 1 Treatment initiated at home by CF Nurse 
Topical Mupir  c¢in 2% x 5 days BD 
Fucidic Acid 50 mgJkgJdaily x 5 days 
Rifampicin 20 40mgJkgJdaily x 5 days 
Triclosan 2% for washing 
• Personal hygiene advice 
4. Repeat swabs cmried out 1 week post treatment mad 3 monthly thereafter. 
5. Treatment repeated it" further positive culture 
6. Fol lowing 3 ~d positive culture move to step 2 
Intravenous Teicoplanin 10 15mgJkgJdaily 12 hourly x 3 
Intravenous Teicoplanin 10 15mgJkgJdaily once daily (serum levels day 4) 
total 14 days 
7. Al l  patients attend separate clinic and admission i f  necessary to isolation ward 
until 1 year free of MRSA 
Results 19 patients 14 males and 5 females; 6/19 sputum and nasal positive; 12/19 
sputum positive; 1/19 sputum, nasal and perineum positive; 9 patients cleared 
fol lowing 1 course of oral treatment; 4 patients cleared fol lowing 2 courses of oral 
treatment; 3 patients required Step 2 of the protc~ol to clear; 2 patient were not 
cleared on transfer to another unit; 1 patient remains colonized. 
Conclusion Treatment as described has successfully eradicated MRSA from 16/19 
patients. 
This small subjective study looks at the use of complementary therapy (C~f) by 
patients attending the cystic fibrosis clinic in Aberdeen. 42 questionnaires (Q) were 
sent asking whether patients had used may CT, mad i f  so, whether they had found it 
helpful. The term C~I" was explained as "altemative treatments eg aromatherapy, 
homeopathy, acupuncture etc." 
22 Qs were returned (52%). 6 patients had tried some form of C~I ". 4 patients had 
tried homeopathy, 2 had tried aromatherapy and 3 had tried acupuncture, 
reflexology and reiki. 5 of these therapies had been financed privately, one by the 
NHS and one by other means. 5 of the 6 patients used fully qualif ied registered 
practitioners. One patient continues to use homeopathy. 
Comments on effectiveness of C~I': "difficult to say but occasionally appeared to 
prevent infection"; "bril l iant cured headaches, tomach aches etc."; "I didn't feel 
any benefit"; "very effective most of the t ime always gave some benefit"; "very 
relaxing but I suppose you would have to do it on a regular basis to comment fully"; 
"failed to bring back sense of smell  but good for pain relieF'. 
8 of 22 patients said they would be wi l l ing to try C~I" alongside conventional 
treatment, 5 said "maybe", mad 2 said "no". 15 patients thought reatment should be 
financed by the NHS. 
Comments on the f inancing of CT included: "it should be assessed as to how much 
benefit it gives the patient a marked improvement should lead to NHS funding"; "I 
do not bel ieve that funds should be drawn away from existing research and 
treatments"; NHS, it" the patient could prove they would benefit from it". 
In conclusion, it would appear that this appears to be a topic of interest to patients. 
CF patients use CT and this should be taken into account when discussion treatment 
options. Further studies need to be undertaken i  this field. 
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Cystic Fibrosis parents support new cohort groups to prevent cross 
infection 
R. McDonaldl,  Y. Belessis 12, S. Dixon 1, J. Morton 1; 
~Departrnent of Respiratory Medicine, Sydney ChiMren's Hospital, Australia; 
2School of Women's arm Children's Heahh, University of New South Wales, Sydney, 
Australia 
Children with Cystic Fibrosis (CF) may become chronically infected with 
pathogens acquired from the environment or tbrough person to person 
transmission. Recent consensus tatements provide recommendations to minimize 
cross infection. We developed a CF infection control guidel ine and cohorted our 
clinic into f ive different coloured groups, (Pseudomonas (Ps) positive, Ps negative, 
Ps mutiresistant, MRSA, and Stenotrophomonas) according to results of tbree 
sputum cultures]bronchoalveolar lavage specimens obtained over the previous six 
months. Aims: To assess parent attitudes to cohorting one year after its introduction. 
Methods: A parent education ight mad an information package was provided to 
inform parents of the new cohort groups mad reasons for this. Parent attitudes 
regarding the change were assessed by anonymous questionnaire 12 months after 
the intervention. 74 of 120 families (62%) replied. Al l  responses were positive, 80% 
"strongly agreeing" with the need for cohorting and 20% "agreeing". Perceived 
benefits were reduced cross infection and improved efficiency of clinics. 86% of 
families found the adjustment "not difficult". 14% found the change 'Mightly 
difficult". Reasons primari ly were due to the emotional effects of isolation 
particularly amongst adolescent patients, reduced flexibil ity ha appointments and 
two families were concemed about possible stigmatisation. Conclusion: CF famil ies 
in our clinic understand and overwhelmingly support cohorting to minimize cross 
infection. 
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M. Pr cesmans, L. B oulanger, K. De Bceck 
CFcentre, University Hospital, Leuve~ Belgium 
Aim:  survey on nebuliser use in our CF clinic: type of nebuliser, the functional and 
hygienic state of the apparatus and the cleaning method used at home. 
Methods: We asked patients to bring their nebulisers in during a routine clinic or 
hospitalization. The fol lowing parts were checked: the outside of the nebuliser, the 
inside filter, the air tube, drug reservoir and mouthpiece. A pressure check was 
performed for the mechanic nebulisers. Patients were interviewed about their 
c leaning routine of the nebuliser and its parts. 
Results: 48 nebulisers were checked from 40 patients: 47 mechanic and 1 ultrasonic 
device. 44 mechanic nebuliser s worked on electric power (39 Pari BoyFfurbo Boy 
and 5 Porta Neb) and 3 nebulisers were portable with batteries (2 Pari Universals, 
l lmpec Mobilair). 16 patients used more than 1 apparatus at home but only 7 of 
them brought both nebuliser s in for the check. 
15/48 nebuliser s were dirty on the outside mad some were sticky; 26/48 nebuliser s 
had a dirty filter; 6 air tubes were dirty inside; 10 drug reservoirs were damp and 2 
were dirty ; 3 mechanic nebuliser s had an insufficient pressure 2 drug reservoirs had 
an insufficient pressure. A total of 10 different cleaning methods were reported (e.g. 
from "carefully drying every part" to "no cleaning at all ?",4 medication cups had 
to be disposed of because they were too dirty. Only 5 devices were ha "top 
condition". 
Conclusions: Most patients use mechanic devices. Although all patients receive 
initial instruction on nebuliser use and maintenance, the majority of nebulisers 
(43/48) were no longer suitable for further use because of hygienic or teclmical 
reasons mad most patients were advised to either change certain parts l ike filter, air 
tubes, medication cups. The results call for an annual checkup and regular 
information about maintenance of the nebuliser. 
